v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 5,697 $ 3,828 $ 15,686 $ 9,394
Operating expenses:        
Research and development 27,262 17,674 73,077 47,039
General and administrative 5,346 5,151 16,606 15,433
Total operating expenses 32,608 22,825 89,683 62,472
Loss from operations (26,911) (18,997) (73,997) (53,078)
Interest income 32 4 56 421
Interest expense (984) (493) (2,921) (1,251)
Change in fair value of warrant liability 1,836   14,117  
Net loss applicable to common stockholders $ (26,027) $ (19,486) $ (62,745) $ (53,908)
Net loss per share applicable to common stockholders - basic and diluted $ (0.41) $ (0.43) $ (1.01) $ (1.19)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 62,928,299 45,781,638 62,394,819 45,137,331

Source